Dr. Una Ryan has extensive experience leading public, private and non-profit companies. Her current board positions include: Cortexyme, NASDAQ CRTX, RenovoRx and Elemental Machines. She was Chair of The Bay Area BioEconomy Initiative, now combined with CLSI (California Life Sciences Institute) and was formerly on the board of BIO, BayBio and Chair of MassBio. She also serves on the Boards of Cambridge in America, Bristol University US Foundation and San Francisco Art Institute.
Dr. Ryan is an investor concentrating on women-led ventures. She is an LP at Breakout Ventures, Managing Director of Golden Seeds, and a partner in Astia Angel. She has a portfolio of approximately 35 start-ups in the Bay Area and Boston focusing heavily on synthetic biology and medtech.